U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07244094) titled 'A Study on Predicting the Risk of Distant Metastasis in Breast Cancer Using AI-Generated Spatial Pathological Maps' on Nov. 17.
Brief Summary: The goal of this observational study is to develop and validate an artificial intelligence (AI) model for predicting the risk of distant metastasis in patients with primary breast cancer. The main question it aims to answer is:
Can a multimodal AI model, trained on routinely available histopathological images, accurately predict the long-term risk of breast cancer metastasis?
Researchers will analyze existing hematoxylin and eosin (H&E) and immunohistochemistry (IHC) stained tissue slides f...